iotaSciences
Private Company
Funding information not available
Overview
iotaSciences is a private, tools-and-services company operating in the high-growth cell therapy and regenerative medicine sector. Its core value proposition is providing automated, gentle, and efficient solutions for single-cell manipulation, a critical bottleneck in advanced cell biology research and therapeutic development. By miniaturizing processes to nanoliter volumes, the company aims to reduce costs, improve monoclonality assurance, and accelerate the creation of precisely engineered cell lines for its clients in academia and industry. The business model combines the sale/use of proprietary instrumentation with fee-for-service laboratory work, positioning it as an enabler for next-generation therapies.
Technology Platform
Automated single-cell isolation and cloning systems using proprietary low-volume GRID culture chambers for nanoliter-scale cell dispensing and culture. Focus on gentle handling and high viability for sensitive cells like iPSCs.
Opportunities
Risk Factors
Competitive Landscape
iotaSciences competes in the single-cell isolation and cloning market against companies like Berkeley Lights (now part of Bruker), Cytena (part of BICO), Millenyi Biotec (CliniMACS), and other providers of fluorescence-activated cell sorting (FACS) and microfluidic platforms. Its differentiation lies in its specific focus on gentleness and viability for challenging cells like iPSCs, its nanoliter-volume GRID technology, and its integrated service offering for gene-editing.